Higher dose of Pfizer-Lilly drug helps reduce back pain in study
February 19, 2019 at 06:56 AM EST
Pfizer and Eli Lilly said on Tuesday that a higher dose of their non-opioid drug tanezumab succeeded in reducing chronic low back pain in patients in a late-stage clinical study.